New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 28, 2014
09:21 EDTC, CETV, OVTI, ELGX, CLSN, GALE, ITMN, MDVN, DECK, CGEN, REGI, MELI, ENDO, SOHU, NIHD, QCOR, DDD, TWXOn The Fly: Pre-market Movers
UP AFTER EARNINGS: 3D Systems (DDD), up 2.7%... MercadoLibre (MELI), up 12.7%... Renewable Energy (REGI), up 9%... OmniVision (OVTI), up 15%... ALSO HIGHER: Central European Media (CETV) up 23% after Time Warner (TWX) financing deal... Galena (GALE), up 8% after receiving NeuVax notice of acceptance from Australian Patent Office... Celsion (CLSN), up 5.7% after announcing positive interim data from Phase 2 DIGNITY Trial of ThermoDox... Sohu.com (SOHU), up 5% after Marbridge Daily says company rumored to discuss video business merger with Tencent. DOWN AFTER EARNINGS: Endo Health Solutions (ENDP), down 2%... Deckers Outdoor (DECK), down 12.8%... Medivation (MDVN), down 12.5%... Endologix (ELGX), down 25%. ALSO LOWER: Citigroup (C), down 1% after lowerings Q4 results by $235M for fraud at Mexico subsidiary... NII Holdings (NIHD), down 50% after stating Q4 performance negatively impacted outlook on liquidity, shares downgraded at Raymond James... Compugen (CGEN), down 21% after 6M share Spot Secondary priced at $10.50... Questcor (QCOR), down 3% after Bloomberg says FDA reviewing Acthar lab test results... InterMune (ITMN), down 3% after downgraded at Credit Suisse.
News For C;DDD;QCOR;NIHD;SOHU;ENDO;MELI;REGI;CGEN;DECK;MDVN;ITMN;GALE;CLSN;ELGX;OVTI;CETV;TWX From The Last 14 Days
Check below for free stories on C;DDD;QCOR;NIHD;SOHU;ENDO;MELI;REGI;CGEN;DECK;MDVN;ITMN;GALE;CLSN;ELGX;OVTI;CETV;TWX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
August 25, 2014
07:11 EDTITMNInterMune volatility expected to move on Roche acquiring for $8.3B
Subscribe for More Information
07:10 EDTCGENCompugen appoints Krashin CFO
Compugen (CGEN) announced the appointment of Ari Krashin as CFO, effective as of September 9. Krashin previously served as CFO of Gilat Satellite (GILT).
06:39 EDTITMNInterMune downgraded to Hold from Buy at Stifel
Roche (RHHBY) is buying InterMune (ITMN) in a deal valued at $8.3B, or $74 per a share.
August 24, 2014
21:54 EDTELGXPiper Jaffray to hold a bus tour
Subscribe for More Information
20:27 EDTITMNRoche drops pursuit for remainder of Japan's Chugai, Bloomberg says
Subscribe for More Information
13:41 EDTITMNRoche to acquire InterMune for $74.00 per share
Roche (RHHBY) and InterMune (ITMN) announced they have entered into a definitive merger agreement for Roche to fully acquire InterMune at a price of $74.00 per share in an all-cash transaction. This corresponds to a total transaction value of $8.3B on a fully diluted basis. This offer represents a premium of 38% to InterMune's closing price on August 22 and a premium of 63% to InterMune's unaffected closing price on August 12. The merger agreement has been approved by the boards of InterMune and Roche. Under the terms of the merger agreement, Roche will commence a tender offer no later than August 29 to acquire all outstanding shares of InterMune common stock, and InterMune will file a recommendation statement containing the unanimous recommendation of the InterMune board that InterMune's shareholders tender their shares to Roche. The transaction is expected to be neutral to core earnings per share in 2015 and accretive from 2016 onwards. The acquisition of InterMune, a Brisbane, California based biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and fibrotic diseases, will allow Roche to broaden and strengthen its respiratory portfolio globally. Roche plans a smooth transition of InterMune employees and operations into the Roche organization, ensuring readiness for an expected launch of pirfenidone in the US in 2014. The closing of the transaction is expected to take place in 2014.
August 22, 2014
09:36 EDTCActive equity options trading on open
Subscribe for More Information
06:12 EDTCCitigroup faces restrictions on hedge-fund sales, WSJ reports
Subscribe for More Information
August 21, 2014
10:14 EDTITMNOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:02 EDTCActive calls at CBOE; AAPL C HPQ
Active calls at CBOE; AAPL 8/22/14 100 & 100, C Jan 55, HPQ 8/29/14 36
07:15 EDTGALEGalena announces resignation of CEO Mark Ahn
Galena Biopharma announced that Mark Schwartz, Ph.D., has been appointed as President and CEO, effective immediately. Dr. Schwartz was previously Galena's COO. He replaces Mark Ahn, Ph.D. who has resigned as the President and CEO and as a director of the company to pursue "other long held personal and professional goals." It is expected that Dr. Schwartz will also be appointed to Galena's board.
07:11 EDTCGENCompugen reacquires Baize's financial interest in pipeline product candidates
Subscribe for More Information
06:43 EDTCRegulators up bank warning efforts for poor risk assessment, Reuters says
Subscribe for More Information
06:00 EDTTWXStocks with implied volatility below IV index mean; TWX WAG
Subscribe for More Information
05:32 EDTGALEGalena fired CEO over stock promotion scandal, Feuerstein says
Galena fired its CEO Mark Ahn following a stock promotion scandal, The Street's Adam Feuerstein reported last night, citing a source close to the company. A public announcement is coming today, Feuerstein added.
05:22 EDTITMNInterMune downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo downgraded InterMune to Market Perform citing valuation.
August 20, 2014
06:17 EDTCCitigroup looks to sell Japanese retail banking unit, Reuters says
Subscribe for More Information
05:53 EDTITMNStocks with implied volatility movement; NGD ITMN
Subscribe for More Information
August 19, 2014
13:08 EDTCCitigroup tells appeals court Agentina banking license at risk, Reuters reports
Subscribe for More Information
12:14 EDTCCitigroup considers selling Japan retail-banking unit, WSJ reports
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use